162 related articles for article (PubMed ID: 29198022)
1. Hyperthyroid patients without Graves' orbitopathy are not at increased risk of developing glaucoma: a nationwide Danish register-based case-control study.
Brandt F; Thvilum M; Hegedüs L; Brix TH
Endocrine; 2018 Jan; 59(1):137-142. PubMed ID: 29198022
[TBL] [Abstract][Full Text] [Related]
2. Graves' disease and toxic nodular goiter are both associated with increased mortality but differ with respect to the cause of death: a Danish population-based register study.
Brandt F; Thvilum M; Almind D; Christensen K; Green A; Hegedüs L; Brix TH
Thyroid; 2013 Apr; 23(4):408-13. PubMed ID: 23253072
[TBL] [Abstract][Full Text] [Related]
3. Graves' Disease and Toxic Nodular Goiter, Aggravated by Duration of Hyperthyroidism, Are Associated with Alzheimer's and Vascular Dementia: A Registry-Based Long-Term Follow-Up of Two Large Cohorts.
Folkestad L; Brandt F; Lillevang-Johansen M; Brix TH; Hegedüs L
Thyroid; 2020 May; 30(5):672-680. PubMed ID: 31984866
[No Abstract] [Full Text] [Related]
4. Death by Suicide in Graves' Disease and Graves' Orbitopathy: A Nationwide Danish Register Study.
Ferløv-Schwensen C; Brix TH; Hegedüs L
Thyroid; 2017 Dec; 27(12):1475-1480. PubMed ID: 29084476
[TBL] [Abstract][Full Text] [Related]
5. Mortality in Graves' orbitopathy is increased and influenced by gender, age and pre-existing morbidity: a nationwide Danish register study.
Schwensen CF; Brandt F; Hegedüs L; Brix TH
Eur J Endocrinol; 2017 Jun; 176(6):669-676. PubMed ID: 28258132
[TBL] [Abstract][Full Text] [Related]
6. Hyperthyroidism is associated with work disability and loss of labour market income. A Danish register-based study in singletons and disease-discordant twin pairs.
Brandt F; Thvilum M; Hegedüs L; Brix TH
Eur J Endocrinol; 2015 Nov; 173(5):595-602. PubMed ID: 26405237
[TBL] [Abstract][Full Text] [Related]
7. No link between season of birth and subsequent development of Graves' disease or toxic nodular goitre: a nationwide Danish register-based study.
Sivalingam S; Thvilum M; Brix TH; Hegedüs L; Brandt F
Endocr Connect; 2018 Aug; 7(10):1090-5. PubMed ID: 30139815
[TBL] [Abstract][Full Text] [Related]
8. Hyperthyroidism and psychiatric morbidity: evidence from a Danish nationwide register study.
Brandt F; Thvilum M; Almind D; Christensen K; Green A; Hegedüs L; Brix TH
Eur J Endocrinol; 2014 Feb; 170(2):341-8. PubMed ID: 24282192
[TBL] [Abstract][Full Text] [Related]
9. No evidence of a causal relationship between hypothyroidism and glaucoma: A Danish nationwide register-based cohort study.
Thvilum M; Brandt F; Brix TH; Hegedüs L
PLoS One; 2018; 13(2):e0192311. PubMed ID: 29444121
[TBL] [Abstract][Full Text] [Related]
10. Increased Cardiovascular Mortality and Morbidity in Patients Treated for Toxic Nodular Goiter Compared to Graves' Disease and Nontoxic Goiter.
Giesecke P; Rosenqvist M; Frykman V; Friberg L; Wallin G; Höijer J; Lönn S; Törring O
Thyroid; 2017 Jul; 27(7):878-885. PubMed ID: 28471268
[TBL] [Abstract][Full Text] [Related]
11. COMPARISON OF CARDIAC ARRHYTHMIA TYPES BETWEEN HYPERTHYROID PATIENTS WITH GRAVES' DISEASE AND TOXIC NODULAR GOITER.
Turan E; Can I; Turan Y; Uyar M; Cakır M
Acta Endocrinol (Buchar); 2018; 14(3):324-329. PubMed ID: 31149279
[TBL] [Abstract][Full Text] [Related]
12. Relationship between the number and impact of stressful life events and the onset of Graves' disease and toxic nodular goitre.
Matos-Santos A; Nobre EL; Costa JG; Nogueira PJ; Macedo A; Galvão-Teles A; de Castro JJ
Clin Endocrinol (Oxf); 2001 Jul; 55(1):15-9. PubMed ID: 11453947
[TBL] [Abstract][Full Text] [Related]
13. Anti-nuclear autoantibodies in Graves' disease and Graves' orbitopathy.
Lanzolla G; Puccinelli L; Giudetti M; Comi S; Menconi F; Maglionico MN; Posarelli C; Figus M; Marcocci C; Marinò M
J Endocrinol Invest; 2023 Feb; 46(2):337-344. PubMed ID: 36030301
[TBL] [Abstract][Full Text] [Related]
14. Improved quality of life in hyperthyroidism patients after surgery.
Bukvic B; Zivaljevic V; Sipetic S; Diklic A; Tausanovic K; Stojanovic D; Stevanovic D; Paunovic I
J Surg Res; 2015 Feb; 193(2):724-30. PubMed ID: 25167783
[TBL] [Abstract][Full Text] [Related]
15. Morbidity before and after the diagnosis of hyperthyroidism: a nationwide register-based study.
Brandt F; Thvilum M; Almind D; Christensen K; Green A; Hegedüs L; Brix TH
PLoS One; 2013; 8(6):e66711. PubMed ID: 23818961
[TBL] [Abstract][Full Text] [Related]
16. Duration of Hyperthyroidism and Lack of Sufficient Treatment Are Associated with Increased Cardiovascular Risk.
Lillevang-Johansen M; Abrahamsen B; Jørgensen HL; Brix TH; Hegedüs L
Thyroid; 2019 Mar; 29(3):332-340. PubMed ID: 30648498
[TBL] [Abstract][Full Text] [Related]
17. Risk Factors for Graves' Orbitopathy; the Australian Thyroid-Associated Orbitopathy Research (ATOR) Study.
Khong JJ; Finch S; De Silva C; Rylander S; Craig JE; Selva D; Ebeling PR
J Clin Endocrinol Metab; 2016 Jul; 101(7):2711-20. PubMed ID: 27055083
[TBL] [Abstract][Full Text] [Related]
18. Clinical outcome of radioiodine treatment of hyperthyroidism: a follow-up study.
Berg G; Michanek A; Holmberg E; Nyström E
J Intern Med; 1996 Feb; 239(2):165-71. PubMed ID: 8568485
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for developing thyroid-associated ophthalmopathy among individuals with Graves disease.
Stein JD; Childers D; Gupta S; Talwar N; Nan B; Lee BJ; Smith TJ; Douglas R
JAMA Ophthalmol; 2015 Mar; 133(3):290-6. PubMed ID: 25502604
[TBL] [Abstract][Full Text] [Related]
20. [Soluble forms of adhesion molecules sELAM-1 and sICAM-1 in Graves disease and toxic nodular goiter].
Modelska-Ziółkiewicz A; Gembicki M; Sowiński J
Pol Arch Med Wewn; 2003 May; 109(5):463-8. PubMed ID: 14768174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
